Paul B Manning insider trades
Open-market stock purchases and sales by Paul B Manning, Unknown at Candel Therapeutics, Inc, from SEC Form 4 filings since Feb 10, 2016.
Track record: 33% of 45 scored buys are up 5% or more since purchase, averaging +9%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 30, 2026 | CADL Candel Therapeutics, Inc | Bought (not open market) | $19K |
| Jun 23, 2026 | CADL Candel Therapeutics, Inc | Bought (not open market) | — |
| Jun 16, 2026 | LQDA Liquidia Corp | Bought (not open market) | — |
| Jun 4, 2026 | LQDA Liquidia Corp | Sold | $1.2M |
| Jun 4, 2026 | LQDA Liquidia Corp | Sold | $727K |
| Jun 4, 2026 | LQDA Liquidia Corp | Sold | $5.7M |
| Jun 4, 2026 | LQDA Liquidia Corp | Sold | $4.4M |
| Jun 4, 2026 | LQDA Liquidia Corp | Sold | $812K |
| Mar 31, 2026 | CADL Candel Therapeutics, Inc | Bought (not open market) | $19K |
| Feb 23, 2026 | CADL Candel Therapeutics, Inc | Bought | $3M |
| Feb 11, 2026 | LQDA Liquidia Corp | Bought (not open market) | $2.3M |
| Nov 25, 2025 | VRCA Verrica Pharmaceuticals Inc | Bought | $4.3M |
| Nov 25, 2025 | VRCA Verrica Pharmaceuticals Inc | Bought | $5.8M |
| Nov 25, 2025 | VRCA Verrica Pharmaceuticals Inc | Bought | $11.7M |
| Nov 25, 2025 | VRCA Verrica Pharmaceuticals Inc | Bought | $2.2M |
Companies traded
- CADL Candel Therapeutics, Inc: 6 buys, last Jun 30, 2026
- LQDA Liquidia Corp: 4 buys, 9 sales, last Jun 16, 2026
- VRCA Verrica Pharmaceuticals Inc: 29 buys, last Nov 25, 2025
- TSHA Taysha Gene Therapies, Inc: 13 buys, last May 30, 2025
- ABOS Acumen Pharmaceuticals, Inc: 1 buy, last Jul 6, 2021
- DOVA Dova Pharmaceuticals Inc: 19 buys, last Nov 12, 2019
- AVXS AveXis, Inc: 1 sale, last May 15, 2018